Advancing today’s discoveries to improve health for all.

Reminder: NIH Introduced New Training Requirement for Research Disclosure Compliance (NOT‑OD‑25‑133)

NIH

NIH Notice NOT‑OD‑25‑133 introduced a new policy requiring institutions that receive NIH funding to provide mandatory training on “Other Support” disclosure for all Senior/Key Personnel.

Effective October 1, 2025, organizations must implement this training and maintain a written, enforced policy to ensure compliance.

The policy focuses on improving transparency by requiring researchers to disclose all research support, including financial and non‑financial resources, affiliations and activities, regardless of monetary value or where the support originates.

 

picture of the NIH building

The National Institutes of Health (NIH) has introduced a new requirement for organizations that receive NIH funding. Under Notice NOT‑OD‑25‑133, institutions must provide training to certain researchers on how to properly disclose their research support.

Starting October 1, 2025, all Senior and Key Personnel working on NIH-funded projects must complete training on “Other Support” disclosure.

“Other Support” includes any resources that support a researcher’s work, whether they are financial or non‑financial and regardless of their source.

Organizations receiving NIH funding are responsible for:

  • Providing required training to applicable researchers
  • Maintaining a written policy for disclosure compliance
  • Ensuring personnel understand what must be reported

Researchers must report:

  • All active and pending research support
  • Affiliations and collaborations
  • Financial and in‑kind resources such as equipment, space or personnel

These disclosures are required even if the support has no monetary value.

This new requirement is part of NIH’s broader effort to improve research transparency and integrity. It helps ensure that all research activities and funding sources are clearly reported and understood.

Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.